Suchergebnisse - "Sasaki, Hirofumi"

PubPharm (80)

1

Receiver aperture and multipath effects on power loss and modal crosstalk in a THz wireless link using orbital-angular-momentum multiplexing

enthalten in: Scientific reports | 2022

von Su, X. | Zhang, R. | Zhao, Z. | +14

2

Utilizing multiplexing of structured THz beams carrying orbital-angular-momentum for high-capacity communications

enthalten in: Optics express | 2022

von Zhou, H. | Su, X. | Minoofar, A. | +14

3

Methods of treating anxiety by administering a substituted quinolone

enthalten in: Europäisches Patentamt | 2022

von ITO NOBUAKI | SASAKI HIROFUMI | TAI KUNINORI | +1

4

Effect of Changing Surgical Instruments Before Wound Closure to Prevent Wound Infection in Lower GI Surgery : A Randomized Controlled Trial

enthalten in: Diseases of the colon and rectum | 2022

von Kuwahara, R. | Uchino, M. | Ikeuchi, H. | +10

5

Modal coupling and crosstalk due to turbulence and divergence on free space THz links using multiple orbital angular momentum beams

enthalten in: Scientific reports | 2021

von Zhao, Z. | Zhang, R. | Song, H. | +13

6

Incidence, Risk Factors and Outcomes of Cancer of the Anal Transitional Zone in Patients with Ulcerative Colitis

enthalten in: Journal of Crohn's & colitis | 2020

von Horio, Y. | Uchino, M. | Bando, T. | +6

7

HETEROCYCLIC COMPOUNDS FOR TREATING OR PREVENTING DISORDERS CAUSED BY REDUCED NEUROTRANSMISSION OF SEROTONIN, NOREPHNEPHRINE OR DOPAMINE

enthalten in: Europäisches Patentamt | 2020

von ITO NOBUAKI | SASAKI HIROFUMI | TAI KUNINORI | +1

8

Method of treating disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine

enthalten in: Europäisches Patentamt | 2020

von ITO NOBUAKI | SASAKI HIROFUMI | TAI KUNINORI | +1

9

Functional Outcomes and Quality of Life in Elderly Patients after Restorative Proctocolectomy for Ulcerative Colitis

enthalten in: Digestion | 2020

von Minagawa, T. | Ikeuchi, H. | Kuwahara, R. | +5

10

HETEROCYCLIC COMPOUNDS FOR TREATING OR PREVENTING DISORERS CAUSED BY REDUCED NEUROTRANSMISSION OF SEROTONIN, NOREPHNEPHRINE OR DOPAMINE

enthalten in: Europäisches Patentamt | 2019

von ITO NOBUAKI | SASAKI HIROFUMI | TAI KUNINORI | +1

1
2
3
4
5
6
7
8
Nächster »
[8]